• Title of article

    The therapeutic effect of autologous bone marrow mesenchymal stem cells to prevent the progress of chronic allograft nephropathy

  • Author/Authors

    Gholami, Farhad Department of Internal Medicine - Faculty of Medicine - Mazandaran University of Medical Sciences, Mazandaran, Iran , Ghasemi, Ali Department of Hematology and Pediatrics - Mashhad University of Medical Sciences, Mashhad, Iran , Bahrami, Ahmad Reza Department of Biology - Faculty of Sciences - Ferdowsi University Of Mashhad, Mashhad, Iran , Bidkhouri, Hamid Reza Department of Biology - Faculty of Sciences - Ferdowsi University Of Mashhad, Mashhad, Iran , Naderi Mishkin, Hojat Academic Center for Education - Culture and Research (ACECR) - Stem Cell and Regenerative Medicine - Mashhad University of Medical Sciences, Mashhad, Iran , Pezeshki Rad, Masoud Associate Professor of Radiology - Mashhad University of Medical Sciences, Mashhad, Iran , Sharifipour, Farzaneh Division of Nephrology and Hypertension - Department of Internal Medicine - Mashhad University of Medical Sciences, Mashhad, Iran

  • Pages
    5
  • From page
    1
  • To page
    5
  • Abstract
    Progenitor cells or mesenchymal stem cells are new cells, with renovation and regeneration ability and tissues repair. In recent years, administration of stem cells has been introduced to treat a variety of diseases including chronic allograft injury (CAI). It seems that stem cells can create a turning point in regenerative medicine through repair, replacement with damaged tissues or with their paracrine effects.
  • Keywords
    Mesenchymal stem cells , End-stage renal disease , Chronic allograft nephropathy
  • Journal title
    Journal of Renal Injury Prevention
  • DOI
    10.15171/jrip.2019.01
  • Serial Year
    2018
  • Journal title
    Journal of Renal Injury Prevention
  • Record number

    2435660

    • Link To Document
    https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=2435660